| Recruiting | Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Ot NCT07227415 | Pfizer | Phase 1 / Phase 2 |
| Not Yet Recruiting | SL-28 for Advanced Solid Tumours NCT07341737 | Second Life Therapeutics | Phase 1 / Phase 2 |
| Not Yet Recruiting | Stereotactic Body RadioTherapy With Continuous Tracking for Primary and Secondary Renal Cancer NCT07285538 | IRCCS San Raffaele | N/A |
| Recruiting | Prospective Observational Trial of Image-guided Ablative STereotactic bOdy Radiation Therapy for Primary kidNe NCT07299357 | Istituto Clinico Humanitas | — |
| Recruiting | Women With isoLated acUte cyStitis and Macroscopic Hematuria. Is Further Investigation Needed? NCT07037589 | Vastra Gotaland Region | — |
| Recruiting | A Study of BL-B01D1+TKI±Pembrolizumab in Patients With Locally Advanced or Metastatic Renal Cancer NCT06962787 | Sichuan Baili Pharmaceutical Co., Ltd. | Phase 2 |
| Recruiting | Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers NCT06967961 | Institut Claudius Regaud | N/A |
| Recruiting | Occupational Situation and Return to Work of Urological Patients NCT07088536 | Jagiellonian University | — |
| Enrolling By Invitation | Head-to-Head Evaluation of the Cancer Ontology Supervised Multimodal Orchestration (COSMO) AI System Versus Pa NCT07307157 | Harvard Medical School (HMS and HSDM) | — |
| Recruiting | Application of the "Off-Clamp And Sutureless" Technique in Robot-Assisted Partial Nephrectomy NCT07141225 | Shao Pengfei | N/A |
| Not Yet Recruiting | Comparison Between HUGO RAS Robotic Platform and Da Vinci Robotic Platform NCT06844513 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | N/A |
| Recruiting | Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology NCT07303725 | Palo Alto Veterans Institute for Research | — |
| Recruiting | Prehabilitation Prior to Surgery for Kidney Tumors NCT06745609 | Herlev and Gentofte Hospital | N/A |
| Recruiting | Comparison Between Epidural Analgesia and Intrathecal Opioid Analgesia for Pain Management in Open Nephrectomy NCT06595329 | University Hospital of Split | Phase 1 |
| Recruiting | CD70-targeted immunoPET Imaging of Malignant Cancers NCT06852638 | RenJi Hospital | N/A |
| Active Not Recruiting | Renal Tumour Imaging Using MRI NCT07173140 | University College, London | N/A |
| Terminated | A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AUR 109 in Patients With Col NCT06760702 | Aurigene Discovery Technologies Limited | Phase 2 |
| Recruiting | Dual-energy SPEctral CT to Evaluate Response to First-line Therapies in Patients With Metastatic Clear Cell RE NCT06863857 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | — |
| Not Yet Recruiting | Study to Compare Two Partial Nephrectomy Techniques for Renal Tumors: Robot-assisted vs Videolaparoscopic NCT06441851 | Instituto do Cancer do Estado de São Paulo | N/A |
| Recruiting | Planning Operative Strategy Using a Digital Renal Artery Clamping Tool NCT06536439 | University Hospital, Ghent | N/A |
| Completed | Navigated Partial Nephrectomy NCT07315100 | The Netherlands Cancer Institute | N/A |
| Recruiting | Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors NCT06239194 | ModeX Therapeutics, An OPKO Health Company | Phase 1 / Phase 2 |
| Not Yet Recruiting | A Randomized Controlled Trial of the Safety and Efficacy of Robotic Telesurgery Versus Laparoscopic Surgery NCT06369597 | Sun Yat-sen University | N/A |
| Recruiting | Spinal Morphine or Intravenous Lidocaine in Robot-assisted Upper Urologic Surgery NCT06349668 | Hans Bahlmann | Phase 3 |
| Active Not Recruiting | The HistoSonics Edison™ System for Treatment of Primary Solid Renal Tumors Using Histotripsy (#HOPE4KIDNEY) NCT05820087 | HistoSonics, Inc. | N/A |
| Recruiting | A Study of Ward Admissions for Haematuria NCT07395037 | British Urology Researchers in Surgical Training | — |
| Recruiting | Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus NCT05969496 | University of Colorado, Denver | Phase 2 |
| Unknown | HPI Effect in Robotic Urological Surgery on AKI NCT06051162 | Ewha Womans University Mokdong Hospital | N/A |
| Recruiting | A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers NCT05873686 | Nuvectis Pharma, Inc. | Phase 1 |
| Recruiting | NSAID Use After Robotic Partial Nephrectomy NCT05842044 | University of Miami | Phase 2 |
| Terminated | Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccR NCT05935748 | NiKang Therapeutics, Inc. | Phase 2 |
| Enrolling By Invitation | KIDNEY-PAGER: Analysis of Circulating Tumor DNA as a Biomarker in Renal Cancer - an Observational Trial NCT06145139 | University of Aarhus | — |
| Recruiting | 64Cu-GRIP B in Patients With Advanced Malignancies NCT05888532 | Rahul Aggarwal | Phase 1 / Phase 2 |
| Recruiting | Single-layer Robot-assisted Transperitoneal Retroperitoneal Tubeless Radical Nephrectomy NCT06565598 | The First People's Hospital of Xiushui | N/A |
| Completed | The HistoSonics Investigational System for Treatment of Primary Solid Renal Tumors Using Histotripsy NCT05432232 | HistoSonics, Inc. | N/A |
| Active Not Recruiting | Stereotactic Body Radiotherapy (SBRT) for Medically Inoperable Localised Renal Tumors (SABINA Trial) NCT05817604 | Consorci Sanitari de Terrassa | — |
| Completed | Nephrogreen. Appearances of Exvivo Renal Tumours Under Near-infrared NCT05735977 | Birmingham Women's and Children's NHS Foundation Trust | N/A |
| Unknown | A Study of HB0025 Injection in Patients With Advanced Renal Cancer NCT06222125 | Huabo Biopharm Co., Ltd. | Phase 2 |
| Recruiting | A CCafU-UroCCR Randomized Trial: 3D Image-Guided Robot-AssisTEd Partial Nephrectomy for Renal Complex Tumor (U NCT05572216 | University Hospital, Grenoble | N/A |
| Recruiting | National PROspective Infrastructure for Renal Cell Carcinoma (PRO-RCC) NCT05326620 | PROspective Renal Cancer Cohort Foundation | — |
| Recruiting | Advanced Diffusion Imaging in Renal Cancer Patients NCT06116253 | NYU Langone Health | N/A |
| Recruiting | Decision Aid (DA) for Renal Patients NCT05387863 | NYU Langone Health | N/A |
| Recruiting | Video Education With Result Dependent dIsclosure NCT05225428 | Dana-Farber Cancer Institute | N/A |
| Unknown | Robot-assisted Urological Surgeries Using the MicroHand S Robot NCT05462392 | The Affiliated Hospital of Qingdao University | N/A |
| Unknown | Biomarkers of Angiogenesis for Response to Therapeutic Combination in Advanced or Metastatic Kidney Cancer NCT05285579 | Assistance Publique - Hôpitaux de Paris | — |
| Recruiting | cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease NCT05366881 | Adela, Inc | — |
| Completed | A Study to Describe the Kidney Cancer Patient Population Treatment, and Results in the Hospital District of So NCT05363072 | Pfizer | — |
| Recruiting | The Man Van Project NCT06357416 | Royal Marsden NHS Foundation Trust | N/A |
| Suspended | Study of Minimally-invasive Ablative Renal Therapies (SMART) Registry NCT05210933 | University of Alberta | — |
| Unknown | Treatment of Metastatic Tumors of the Urogenital Area With Cytokine-induced Killer Cells NCT05108077 | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | Phase 1 / Phase 2 |
| Unknown | Exploratory Interventional Study of Prognostic Serum Biomarkers of Cancer Progression NCT05426317 | University Hospital, Clermont-Ferrand | N/A |
| Completed | Gag-layer in the Urothelium of the Human Upper Urinary Tract NCT05400291 | Aarhus University Hospital | — |
| Terminated | A Study of NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma NCT05119335 | NiKang Therapeutics, Inc. | Phase 1 / Phase 2 |
| Recruiting | Renal Cancer Detection With Liquid Biopsy NCT05060783 | Zealand University Hospital | — |
| Recruiting | Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE) NCT04498767 | European Organisation for Research and Treatment of Cancer - EORTC | N/A |
| Recruiting | 68Ga-PSMA PET in the Renal Cell Carcinoma NCT04987086 | Xijing Hospital | N/A |
| Recruiting | Impact of Telemonitoring for the Management of Side Effects in Patients with Melanoma, Lung or Renal Cancer, T NCT04605146 | Hospices Civils de Lyon | N/A |
| Withdrawn | Impact of Perioperative Anesthetic Management on Renal Cancer Progression. NCT06536244 | M.D. Anderson Cancer Center | — |
| Unknown | Microbiome Immunotherapy Toxicity and Response Evaluation NCT04107168 | CCTU- Cancer Theme | — |
| Completed | Assessment of Complications in Patients Who Underwent LPN According to the CCI NCT05823545 | Samsun Liv Hospital | — |
| Completed | Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors NCT04157985 | Dan Zandberg | Phase 3 |
| Recruiting | Stereotactic Magnetic Resonance Guided Radiation Therapy NCT04115254 | Dana-Farber Cancer Institute | N/A |
| Completed | LPN in Patients With High-complex Renal Tumors NCT04933604 | Samsun Liv Hospital | — |
| Withdrawn | Robot-assisted Surgical Resection vs. Cryoablation of Localised Renal Cancer NCT03390413 | Jørgen Bjerggaard Jensen | N/A |
| Unknown | Image Guided RFA/MWA/CRYO of RCC Biomarker Profile Study NCT04392076 | University of Leeds | — |
| Terminated | Study With Bispecific Antibody Engaging T-cells, in Patients With Progressive Cancer Diseases With Positive PS NCT03927573 | AvenCell Europe GmbH | Phase 1 |
| Unknown | MRx0518 in Patients With Solid Tumours Waiting Surgical Removal of the Tumour NCT03934827 | Imperial College London | Phase 1 |
| Completed | Laparoscopic Partial Nephrectomy for cT1 Tumors NCT04213157 | Samsun Liv Hospital | — |
| Terminated | Open vs Robotic Assisted Partial Nephrectomy NCT03849820 | Intuitive Surgical | N/A |
| Active Not Recruiting | 9-ING-41 in Patients With Advanced Cancers NCT03678883 | Actuate Therapeutics Inc. | Phase 2 |
| Recruiting | Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patien NCT03787056 | Hospices Civils de Lyon | N/A |
| Completed | Multiparametric MRI for Diagnosing Small Renal Tumors NCT03470285 | University Hospital, Bordeaux | N/A |
| Recruiting | Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid NCT03755739 | Second Affiliated Hospital of Guangzhou Medical University | Phase 2 / Phase 3 |
| Active Not Recruiting | A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors NCT03693014 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Active Not Recruiting | A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cel NCT03634540 | Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Phase 2 |
| Completed | Effects of Anesthesia on Immunity in Cancer NCT03514550 | Meshalkin Research Institute of Pathology of Circulation | Phase 4 |
| Completed | Study of Nivolumab for Advanced Cancers in India NCT03444766 | Bristol-Myers Squibb | Phase 4 |
| Completed | Safety and Effectiveness of Nivolumab in Recurring Kidney Cancer Participants NCT03568435 | Bristol-Myers Squibb | — |
| Unknown | Zero-ischemia Robot-assisted Partial Nephrectomy Using Near-infrared Fluorescence NCT03679572 | University Hospital, Grenoble | N/A |
| Completed | A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participan NCT03289962 | Genentech, Inc. | Phase 1 |
| Active Not Recruiting | Study of Optimized Management of Nivolumab Based on Response in Patients With Advanced RCC (OMNIVORE Study) NCT03203473 | Toni Choueiri, MD | Phase 2 |
| Recruiting | APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid NCT03175224 | Apollomics Inc. | Phase 2 |
| Completed | Preliminary Evaluation of Uptake of [68Ga]P16-093 in Metastatic Prostate and Renal Cancer NCT03073395 | Five Eleven Pharma, Inc. | Phase 1 |
| Unknown | Study of the Variations of the Blood Pressure After Nephrectomy for Renal Cancer (VAPANCR) NCT03218319 | University Hospital, Angers | N/A |
| Terminated | Atezolizumab in Combination With Entinostat and Bevacizumab in Patients With Advanced Renal Cell Carcinoma NCT03024437 | Roberto Pili | Phase 1 / Phase 2 |
| Unknown | Quality of Life Assessment in Daily Clinical Oncology Practice for Patients With Advanced Renal Cell Carcinoma NCT03062410 | Centre Hospitalier Universitaire de Besancon | N/A |
| Completed | Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies. NCT02947165 | Novartis Pharmaceuticals | Phase 1 |
| Unknown | Complication in Laparoscopic Renal and Adrenal Surgery (CLARAS) NCT05322265 | University of Palermo | — |
| Completed | Does the Use of Hemostatic Clips During the Tumor Resection Step Reduce Blood Loss During Robot-assisted Parti NCT04388917 | Centre Hospitalier Universitaire de Nice | — |
| Completed | A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers NCT02643303 | Ludwig Institute for Cancer Research | Phase 1 / Phase 2 |
| Terminated | MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors NCT02669914 | Washington University School of Medicine | Phase 2 |
| Completed | Study of Pre-operative Combination Therapy With Mogamulizumab and Nivolumab Against Solid Cancer Patients NCT02946671 | Osaka University | Phase 1 |
| Completed | Complications Associated With Partial Nephrectomy for Renal Cancer NCT05168761 | Central Hospital, Nancy, France | — |
| Enrolling By Invitation | Decipher Genomics Resource for Intelligent Discovery NCT02609269 | GenomeDx Biosciences Corp | — |
| Terminated | Everolimus Therapy in People With Birt-Hogg-Dube Syndrome (BHD)-Associated Kidney Cancer or Sporadic Chromopho NCT02504892 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Feasibility of a Consumer Based Accelerometer in Monitoring Outpatient Physical Activity: A Study in Patients NCT02457715 | Duke University | — |
| Completed | Pillars4Life Trial NCT02465892 | Duke University | N/A |
| Completed | Laparoscopic Versus Hand Assisted Laparoscopic Trans-peritoneal Laparoscopic Nephrectomy as One Day Surgery (i NCT02295982 | Zealand University Hospital | N/A |
| Terminated | T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-A*01 Positive NCT02153905 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Unknown | Prospective Analysis of Robot-Assisted Surgery NCT02292914 | Instituto do Cancer do Estado de São Paulo | N/A |
| Recruiting | Kidney Cancer DNA Registry NCT02087852 | Memorial Sloan Kettering Cancer Center | — |
| Completed | T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-DP0401 Positiv NCT02111850 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | Effect of Neuromuscular Block and Arterial PCO2 on Surgical Rating Scale (SRS), Following Reversal With Sugamm NCT01968447 | Leiden University Medical Center | N/A |
| Active Not Recruiting | Ablation of Renal Masses Outcomes Registry (ARMOR): Ablation Procedure and Quality of Life Assessment NCT01888198 | Memorial Sloan Kettering Cancer Center | — |
| Terminated | Vascular Targeted Photodynamic Therapy T1a Renal Tumours NCT01573156 | University of Oxford | Phase 1 / Phase 2 |
| Terminated | Low Dose Naltrexone for Metastatic Melanoma, Castrate Resistant Prostate Cancer and Renal Cancer NCT01650350 | Brown University | Phase 2 |
| Completed | Off Clamp Randomization NCT01732120 | Washington University School of Medicine | N/A |
| Completed | A Feasibility Study for a Multicentre Randomised Controlled Trial to Compare Surgery With Needle Ablation Tech NCT01608165 | Newcastle-upon-Tyne Hospitals NHS Trust | N/A |
| Completed | Mannitol Use During Partial Nephrectomy Prior to Renal Ischemia and Impact on Renal Function Outcomes NCT01606787 | Memorial Sloan Kettering Cancer Center | Phase 3 |
| Active Not Recruiting | Evaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Therapy In Patients With Metastatic NCT01582204 | Memorial Sloan Kettering Cancer Center | N/A |
| Completed | Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia NCT01444456 | Amgen | — |
| Terminated | BEZ235 in Patients With Advanced Renal Cell Carcinoma (RCC) NCT01453595 | Memorial Sloan Kettering Cancer Center | Phase 1 / Phase 2 |
| Terminated | CAR T Cell Receptor Immunotherapy Targeting VEGFR2 for Patients With Metastatic Cancer NCT01218867 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | Stereotactic Radiotherapy for Renal Cancers NCT02811250 | Hospices Civils de Lyon | N/A |
| Completed | Cancer in Patients With Gabapentin (GPRD) NCT01236053 | GlaxoSmithKline | — |
| Recruiting | Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related NCT01109394 | National Cancer Institute (NCI) | — |
| Terminated | A Pilot Study of F-18 Paclitaxel (FPAC) PET for Evaluating Drug Delivery of Solid Tumors in Breast, Lung, Rena NCT01086696 | National Cancer Institute (NCI) | EARLY_Phase 1 |
| Completed | Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD) NCT01138124 | GlaxoSmithKline | — |
| Recruiting | Kidney Cancer Observational Protocol NCT06147349 | IRCCS San Raffaele | — |
| Completed | Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium NCT00896454 | Amgen | Phase 2 |
| Completed | Percutaneous Renal Tumor Cryoablation Followed by Biopsy NCT01012427 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Completed | Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung Cancers NCT01005797 | Medical University of South Carolina | Phase 1 |
| Completed | Study In Patients With Kidney Cancer Treated With Sutent NCT00873210 | Pfizer | — |
| Terminated | Phase 1/2 Study of Metastatic Renal Cancer Using T-Cells Transduced With a T-Cell Receptor Which Recognizes TR NCT00923390 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma NCT00827359 | Beth Israel Deaconess Medical Center | Phase 2 |
| Completed | Mechanisms of Anti-VEGF Induced Hypertension NCT02156310 | Arduino Mangoni | — |
| Completed | Follow-Up Study of Kidney Cancer Patients NCT00656955 | National Cancer Institute (NCI) | — |
| Completed | Evaluating Renal Masses Using Ultrasound Intravenous Microbubble Contrast NCT00671411 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Completed | Phase II Study of Vandetanib in Individuals With Kidney Cancer NCT00566995 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma NCT00531284 | Amgen | Phase 1 / Phase 2 |
| Completed | High-dose Bevacizumab in Advanced Renal Carcinoma Patients NCT00455975 | SCRI Development Innovations, LLC | Phase 2 |
| Completed | Interleukin-2 With Sorafenib (BAY 43-9006) for Unresectable or Metastatic Clear Cell Renal Carcinoma (RCC) and NCT00418496 | Ohio State University Comprehensive Cancer Center | Phase 1 |
| Completed | A Study of ZYC300 Administered With Cyclophosphamide Pre-Dosing NCT00381173 | Eisai Inc. | Phase 1 |
| Completed | Perifosine + Sunitinib Malate for Patients With Advanced Cancers NCT00399152 | AEterna Zentaris | Phase 1 |
| Completed | Phase I Study of Perifosine + Sorafenib for Patients With Advanced Cancers NCT00398814 | AEterna Zentaris | Phase 1 |
| Completed | A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies NCT00441337 | Bristol-Myers Squibb | Phase 1 |
| Completed | CyberKnife for Unresectable Renal Tumors NCT00807339 | Beth Israel Deaconess Medical Center | N/A |
| Completed | Treatment of Patients With Advanced Renal Cancer With a Radiolabeled Antibody, Yttrium-90 Conjugated Chimeric NCT00199875 | Ludwig Institute for Cancer Research | Phase 1 |
| Completed | Safety Study With the Antibody, cG250, and Isotope, 124-Iodine, to Diagnose Patients With Renal Masses. NCT00199888 | Ludwig Institute for Cancer Research | Phase 1 |
| Completed | Pilot Evaluation of 124I-Iodo-Azomycin Galacto-Pyranoside (*IAZGP) Positron Emission Tomography (PET) in the I NCT00588276 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Completed | Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF NCT00458536 | Beth Israel Deaconess Medical Center | Phase 1 / Phase 2 |
| Recruiting | Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders NCT00582621 | Memorial Sloan Kettering Cancer Center | — |
| Recruiting | Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease NCT00026884 | National Cancer Institute (NCI) | — |
| Completed | Spectroscopy With Surface Coils and Decoupling NCT00581815 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Withdrawn | Interferon Alpha-2b (Intron A) for Metastatic or Unresectable Clear Cell Renal Carcinoma NCT00293527 | Ohio State University Comprehensive Cancer Center | Phase 2 |